Related references
Note: Only part of the references are listed.Amyloid in bone marrow smears of patients affected by multiple myeloma
Fara Petruzziello et al.
ANNALS OF HEMATOLOGY (2010)
Left ventricular hypertrophy: Cardiac magnetic resonance may help differentiate amyloidosis from hypertrophic cardiomyopathy
Mikael Mabru et al.
ARCHIVES OF CARDIOVASCULAR DISEASES (2010)
High-Dose Chemotherapy with Autotransplantation in AL Amyloidosis: A Flawed Meta-analysis
Jayesh Mehta et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2010)
Lenalidomide in combination with melphalan and dexamethasone in patients with newly diagnosed AL amyloidosis: a multicenter phase 1/2 dose-escalation study
Philippe Moreau et al.
BLOOD (2010)
Treatment with intravenous melphalan and dexamethasone is not able to overcome the poor prognosis of patients with newly diagnosed systemic light chain amyloidosis and severe cardiac involvement
Sascha Dietrich et al.
BLOOD (2010)
Cardiac Amyloidosis Approaches to Diagnosis and Management
Harit V. Desai et al.
CARDIOLOGY IN REVIEW (2010)
Pitfalls in the Diagnosis of Primary Amyloidosis
Cheng E. Chee et al.
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA (2010)
Currents Concepts on the Immunopathology of Amyloidosis
Anupama Bhat et al.
CLINICAL REVIEWS IN ALLERGY & IMMUNOLOGY (2010)
Amyloidosis relapsing after autologous stem cell transplantation treated with bortezomib: normalization of detectable serum-free light chains and reversal of tissue damage with improved suitability for transplant
Mark W. Brunvand et al.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL (2010)
Nodular senile pulmonary amyloidosis: a unique case confirmed by immunohistochemistry, mass spectrometry, and genetic study
Anja C. Roden et al.
HUMAN PATHOLOGY (2010)
Bortezomib With or Without Dexamethasone in Primary Systemic (Light Chain) Amyloidosis
Efstathios Kastritis et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Bladder Amyloidosis
Adnan Javed et al.
JOURNAL OF UROLOGY (2010)
Laryngeal Amyloidosis Causing Hoarseness and Airway Obstruction
Gregory J. Gallivan et al.
JOURNAL OF VOICE (2010)
Systemic amyloidosis: a challenge for the rheumatologist
Federico Perfetto et al.
NATURE REVIEWS RHEUMATOLOGY (2010)
Amyloid in endomyocardial biopsies
Barbara Kieninger et al.
VIRCHOWS ARCHIV (2010)
Amyloid Load in Fat Tissue Reflects Disease Severity and Predicts Survival in Amyloidosis
Ingrid I. van Gameren et al.
ARTHRITIS CARE & RESEARCH (2010)
Prognostic Significance of Strain Doppler Imaging in Light-Chain Amyloidosis
Jun Koyama et al.
JACC-CARDIOVASCULAR IMAGING (2010)
Echocardiographic Evaluation of Cardiac Amyloid
Wendy Tsang et al.
Current Cardiology Reports (2010)
Prevalence and Origin of Amyloid in Kidney Biopsies
Hanna von Hutten et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2009)
Treatment of patients with advanced cardiac AL amyloidosis with oral melphalan, dexamethasone, and thalidomide
Giovanni Palladini et al.
ANNALS OF HEMATOLOGY (2009)
Role of High-Dose Chemotherapy and Autologous Hematopoietic Cell Transplantation in Primary Systemic Amyloidosis: A Systematic Review
Rahul Mhaskar et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2009)
Weekly and twice-weekly bortezomib in patients with systemic AL amyloidosis: results of a phase 1 dose-escalation study
Donna E. Reece et al.
BLOOD (2009)
Classification of amyloidosis by laser microdissection and mass spectrometry-based proteomic analysis in clinical biopsy specimens
Julie A. Vrana et al.
BLOOD (2009)
Serum free light chain analysis may miss monoclonal light chains that urine immunofixation electrophoreses would detect
Saad P. Shaheen et al.
CLINICA CHIMICA ACTA (2009)
Identification of Amyloidogenic Light Chains Requires the Combination of Serum-Free Light Chain Assay with Immunofixation of Serum and Urine
Giovanni Palladini et al.
CLINICAL CHEMISTRY (2009)
Primary localized cutaneous amyloidosis: a sign of immune dysregulation?
Maurice J. Dahdah et al.
INTERNATIONAL JOURNAL OF DERMATOLOGY (2009)
Cardiac Amyloidosis in a Patient with Multiple Myeloma: A Case Report and Review of Literature
David Sedaghat et al.
JOURNAL OF CLINICAL ULTRASOUND (2009)
International Myeloma Working Group guidelines for serum-free light chain analysis in multiple myeloma and related disorders
A. Dispenzieri et al.
LEUKEMIA (2009)
Treatment of immunoglobulin light chain amyloidosis
Morie A. Gertz et al.
Current Hematologic Malignancy Reports (2009)
Diego)
Angela Dispenzieri et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2008)
CD32B is highly expressed on clonal plasma cells from patients with systemic light-chain amyloidosis and provides a target for monoclonal antibody-based therapy
Ping Zhou et al.
BLOOD (2008)
Predictors of survival in patients with systemic light-chain amyloidosis and cardiac involvement initially ineligible for stem cell transplantation and treated with oral melphalan and dexamethasone
D. Lebovic et al.
BRITISH JOURNAL OF HAEMATOLOGY (2008)
Efficacy of bortezomib in systemic AL amyloidosis with relapsed/refractory clonal disease
Ashutosh D. Wechalekar et al.
HAEMATOLOGICA (2008)
Long-term Follow-up of Plasma Cells in Bone Marrow and Serum Free Light Chains in Primary Systemic AL Amyloidosis
Takuhiro Yoshida et al.
INTERNAL MEDICINE (2008)
Troponin T level as an exclusion criterion for stem cell transplantation in light-chain amyloidosis
Morie Gertz et al.
LEUKEMIA & LYMPHOMA (2008)
Serum uric acid: Novel prognostic factor in primary systemic amyloidosis
Shaji Kumar et al.
MAYO CLINIC PROCEEDINGS (2008)
High-Dose Melphalan versus Melphalan plus Dexamethasone for AL Amyloidosis
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Long-term outcome-of patients with AL amyloidosis treated with high-dose melphalan and stem-cell transplantation
Vaishali Sanchorawala et al.
BLOOD (2007)
Effect of hematologic response on outcome of patients undergoing transplantation for primary amyloidosis: importance of achieving a complete response
Morie A. Gertz et al.
HAEMATOLOGICA (2007)
High-dose melphalan versus melphalan plus dexamethasone for AL amyloidosis
Arnaud Jaccard et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
Treatment with oral melphalan plus dexamethasone produces long-term remissions in AL amyloidosis
Giovanni Palladini et al.
BLOOD (2007)
Lenalidomide and dexamethasone in the treatment of AL amyloidosis: results of a phase 2 trial
Vaishali Sanchorawala et al.
BLOOD (2007)
Safety and efficacy of risk-adapted cyclophosphamide, thalidomide, and dexamethasone in systemic AL amyloidosis
Ashutosh D. Wechalekar et al.
BLOOD (2007)
The activity of lenalidomide with or without dexamethasone in patients with primary systemic amyloidosis
Angela Dispenzieri et al.
BLOOD (2007)
Transplantation for amyloidosis
Morie A. Gertz et al.
CURRENT OPINION IN ONCOLOGY (2007)
Dermatologic adverse effects of lenalidomide therapy for amyloidosis and multiple myeloma
Hans P. Sviggum et al.
ARCHIVES OF DERMATOLOGY (2006)
The spectrum of localized amyloidosis: A case series of 20 patients and review of the literature
Michelle L. Biewend et al.
AMYLOID-JOURNAL OF PROTEIN FOLDING DISORDERS (2006)
Seeking confidence in the diagnosis of systemic AL (Ig light-chain) amyloidosis: patients can have both monoclonal gammopathies and hereditary amyloid proteins
RL Comenzo et al.
BLOOD (2006)
Prevalence of monoclonal gammopathy of undetermined significance
RA Kyle et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Glycosaminoglycans are part of amyloid fibrils: Ultrastructural evidence in avian AA amyloid stained with cuprolinic blue and labeled with immunogold
E Gruys et al.
AMYLOID-JOURNAL OF PROTEIN FOLDING DISORDERS (2006)
Classification of amyloidosis: misdiagnosing by way of incomplete immunohistochemistry and how to prevent it
Reinhold P. Linke et al.
ACTA HISTOCHEMICA (2006)
Association of melphalan and high-dose dexamethasone is effective and well tolerated in patients with AL (primary) amyloidosis who are ineligible for stem cell transplantation
G Palladini et al.
BLOOD (2004)
Prognostication of survival using cardiac troponins and N-terminal pro-brain natriuretic peptide in patients with primary systemic amyloidosis undergoing peripheral blood stem cell transplantation
A Dispenzieri et al.
BLOOD (2004)
Serum cardiac troponins and N-terminal pro-brain natriuretic peptide: A staging system for primary systemic amyloidosis
A Dispenzieri et al.
JOURNAL OF CLINICAL ONCOLOGY (2004)
Poor tolerance to high doses of thalidomide in patients with primary systemic amyloidosis
A Dispenzieri et al.
AMYLOID-JOURNAL OF PROTEIN FOLDING DISORDERS (2003)
Review of 1027 patients with newly diagnosed multiple myeloma
RA Kyle et al.
MAYO CLINIC PROCEEDINGS (2003)
Low-dose continuous oral melphalan for the treatment of primary systemic (AL) amyloidosis
V Sanchorawala et al.
BRITISH JOURNAL OF HAEMATOLOGY (2002)
Share Paper
